| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.24 | 5e-12 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.23 | 6e-12 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.22 | 3e-11 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-09 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.16 | 9e-07 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |